Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
NEJM Evidence|February 24, 2026
Trifluridine-Tipiracil with and without Bevacizumab in Colorectal CancerMaliha Nusrat, Ruizhi Zhao, Nadeem Khan, et al.Patient Preference and Adherence|April 15, 2024
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative ColitisMaryia Zhdanava, Sumesh Kachroo, Aditi Shah, et al.Current Medical Research and Opinion|August 11, 2023
Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumabMaryia Zhdanava, Zhijie Ding, Ameur M Manceur, et al.Clinical Therapeutics|July 13, 2023
Persistence Among Patients with Crohn Disease Previously Treated with an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic AgentMaryia Zhdanava, Sumesh Kachroo, Ameur M Manceur, et al.Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumabMaryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, et al.Journal of Ethnopharmacology|May 15, 2017
Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic ratsChenxue Zhang, Qian Li, Sisi Lai, et al.Journal of Thrombosis and Thrombolysis|June 30, 2012
Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studiesKuangguo Zhou, Ruizhi Zhao, Zhe Geng, et al.Biomaterials|December 30, 2023
Dual-crosslinking immunostimulatory hydrogel synchronously suppresses pancreatic fistula and pancreatic cancer relapse post-resectionRuizhi Zhao, Qiuqun Xiao, Yuanyuan Wu, et al.Journal of Health Economics and Outcomes Research|November 29, 2023
Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-UpRuizhi Zhao, Zhijie Ding, Parul Gupta, et al.Journal of the American Pharmacists Association : Japha|November 13, 2023
Economic and clinical burden of chronic corticosteroid use in patients with Crohn[apos]s disease initiated on biologic or conventional therapies in the US: A retrospective claims studyMaryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, et al.Pageof 9